These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 19350634)

  • 41. [Glutathione S-transferases (GSTM1, GSTT1 and GSTP1) and N-acetyltransferase 2 polymorphisms and the risk of gastric cancer].
    Hong SH; Kim JW; Kim HG; Park IK; Ryoo JW; Lee CH; Sohn YK; Lee JY
    J Prev Med Public Health; 2006 Mar; 39(2):135-40. PubMed ID: 16615268
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Interaction of the cytochrome P4501A2, SULT1A1 and NAT gene polymorphisms with smoking and dietary mutagen intake in modification of the risk of pancreatic cancer.
    Suzuki H; Morris JS; Li Y; Doll MA; Hein DW; Liu J; Jiao L; Hassan MM; Day RS; Bondy ML; Abbruzzese JL; Li D
    Carcinogenesis; 2008 Jun; 29(6):1184-91. PubMed ID: 18499698
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Construction of Syrian hamster lines congenic at the polymorphic acetyltransferase locus (NAT2): acetylator genotype-dependent N- and O-acetylation of arylamine carcinogens.
    Hein DW; Doll MA; Rustan TD; Gray K; Ferguson RJ; Feng Y
    Toxicol Appl Pharmacol; 1994 Jan; 124(1):16-24. PubMed ID: 8291057
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Polymorphisms of NAT2 in relation to sulphasalazine-induced agranulocytosis.
    Wadelius M; Stjernberg E; Wiholm BE; Rane A
    Pharmacogenetics; 2000 Feb; 10(1):35-41. PubMed ID: 10739170
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cytochrome P450 (CYP) 1A2, sulfotransferase (SULT) 1A1, and N-acetyltransferase (NAT) 2 polymorphisms and susceptibility to urothelial cancer.
    Tsukino H; Kuroda Y; Nakao H; Imai H; Inatomi H; Osada Y; Katoh T
    J Cancer Res Clin Oncol; 2004 Feb; 130(2):99-106. PubMed ID: 14648207
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Acetylator status and N-acetyltransferase 2 gene polymorphisms; phenotype-genotype correlation with the sulfamethazine test.
    Taja-Chayeb L; González-Fierro A; Miguez-Muñoz C; Trejo-Becerril C; Cruz-Hernandez Ede L; Cantu D; Agundez JA; Vidal-Millan S; Gutierrez O; Dueñas-González A
    Pharmacogenet Genomics; 2011 Dec; 21(12):894-901. PubMed ID: 21946899
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Impact of misclassification in genotype-exposure interaction studies: example of N-acetyltransferase 2 (NAT2), smoking, and bladder cancer.
    Deitz AC; Rothman N; Rebbeck TR; Hayes RB; Chow WH; Zheng W; Hein DW; García-Closas M
    Cancer Epidemiol Biomarkers Prev; 2004 Sep; 13(9):1543-6. PubMed ID: 15342459
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Polymorphism of the N-acetyltransferase 2 gene as a susceptibility risk factor for antituberculosis drug-induced hepatitis.
    Huang YS; Chern HD; Su WJ; Wu JC; Lai SL; Yang SY; Chang FY; Lee SD
    Hepatology; 2002 Apr; 35(4):883-9. PubMed ID: 11915035
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Study on Genotyping Polymorphism and Sequencing of N-Acetyltransferase 2 (NAT2) among Al-Ahsa Population.
    Zahra MA; Kandeel M; Aldossary SA; Al-Taher A
    Biomed Res Int; 2020; 2020():8765347. PubMed ID: 32626768
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Genetic polymorphisms in N-acetyltransferase-2 and microsomal epoxide hydrolase, cumulative cigarette smoking, and lung cancer.
    Zhou W; Liu G; Thurston SW; Xu LL; Miller DP; Wain JC; Lynch TJ; Su L; Christiani DC
    Cancer Epidemiol Biomarkers Prev; 2002 Jan; 11(1):15-21. PubMed ID: 11815396
    [TBL] [Abstract][Full Text] [Related]  

  • 51. NAT2 ultra-slow acetylator and risk of anti-tuberculosis drug-induced liver injury: a genotype-based meta-analysis.
    Suvichapanich S; Fukunaga K; Zahroh H; Mushiroda T; Mahasirimongkol S; Toyo-Oka L; Chaikledkaew U; Jittikoon J; Yuliwulandari R; Yanai H; Wattanapokayakit S; Tokunaga K
    Pharmacogenet Genomics; 2018 Jul; 28(7):167-176. PubMed ID: 29781872
    [TBL] [Abstract][Full Text] [Related]  

  • 52. N-acetyl transferase 2 genotypes, meat intake and breast cancer risk.
    Gertig DM; Hankinson SE; Hough H; Spiegelman D; Colditz GA; Willett WC; Kelsey KT; Hunter DJ
    Int J Cancer; 1999 Jan; 80(1):13-7. PubMed ID: 9935222
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Variation in N-acetyltransferase 2 (NAT2), smoking and risk of prostate cancer in the Slovak population.
    Vilčková M; Jurečeková J; Dobrota D; Habalová V; Klimčáková L; Waczulíková I; Slezák P; Kliment J; Sivoňová MK
    Med Oncol; 2014 Jun; 31(6):987. PubMed ID: 24816842
    [TBL] [Abstract][Full Text] [Related]  

  • 54. N-Acetyltransferase 2 (NAT2) polymorphism as a risk modifier of susceptibility to pediatric acute lymphoblastic leukemia.
    Kamel AM; Ebid GT; Moussa HS
    Tumour Biol; 2015 Aug; 36(8):6341-8. PubMed ID: 25804798
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Impact of interaction of polymorphic forms of p53 codon 72 and N-acetylation gene (NAT2) on the risk of lung cancer in the North Indian population.
    Sobti RC; Kaur P; Kaur S; Janmeja AK; Jindal SK; Kishan J; Raimondi S
    DNA Cell Biol; 2009 Sep; 28(9):443-9. PubMed ID: 19558213
    [TBL] [Abstract][Full Text] [Related]  

  • 56. N-acetyltransferase 2 acetylation polymorphism: prevalence of slow acetylators does not differ between atopic dermatitis patients and healthy subjects.
    Brocvielle H; Muret P; Goydadin AC; Boone P; Broly F; Kantelip JP; Humbert P
    Skin Pharmacol Appl Skin Physiol; 2003; 16(6):386-92. PubMed ID: 14528063
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [The associations of polymorphism of N-acetyltransferase 2 gene is associated with antituberculosis drug-induced hepatotoxicity in tuberculosis patients].
    An HR; Wu XQ; Wang ZY; Liang Y; Zhang JX
    Zhonghua Yu Fang Yi Xue Za Zhi; 2011 Jan; 45(1):36-40. PubMed ID: 21418817
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Meat and heterocyclic amine intake, smoking, NAT1 and NAT2 polymorphisms, and colorectal cancer risk in the multiethnic cohort study.
    Nöthlings U; Yamamoto JF; Wilkens LR; Murphy SP; Park SY; Henderson BE; Kolonel LN; Le Marchand L
    Cancer Epidemiol Biomarkers Prev; 2009 Jul; 18(7):2098-106. PubMed ID: 19549810
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Metabolic activation and deactivation of arylamine carcinogens by recombinant human NAT1 and polymorphic NAT2 acetyltransferases.
    Hein DW; Doll MA; Rustan TD; Gray K; Feng Y; Ferguson RJ; Grant DM
    Carcinogenesis; 1993 Aug; 14(8):1633-8. PubMed ID: 8353847
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Differential association for N-acetyltransferase 2 genotype and phenotype with bladder cancer risk in Chinese population.
    Quan L; Chattopadhyay K; Nelson HH; Chan KK; Xiang YB; Zhang W; Wang R; Gao YT; Yuan JM
    Oncotarget; 2016 Jun; 7(26):40012-40024. PubMed ID: 27223070
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.